Is lactate dehydrogenase (LDH) a reliable marker for assessing liver function or diagnosing hepatic disease?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 7, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

LDH is NOT a Reliable or Specific Marker for Liver Function Assessment

LDH is a nonspecific marker of tissue damage that can be elevated in liver disease, but it should NOT be used as a primary test for assessing liver function or diagnosing hepatic disease. 1, 2

Why LDH is Inadequate for Liver Testing

Lack of Specificity

  • LDH elevation reflects tissue damage or increased cellular turnover from numerous conditions including hemolysis, myocardial infarction, kidney disease, muscle damage, infections, and malignancies—not just liver disease 2, 3
  • For any given degree of liver injury, LDH provides no diagnostic advantage over standard liver function tests (aminotransferases, bilirubin, alkaline phosphatase) 1

Limited Diagnostic Value in Hepatic Disease

  • While LDH can be elevated in liver disease, it is mentioned only as an optional test in tumor lysis syndrome panels or as part of broader metabolic assessments—never as a primary liver function marker 1
  • Standard liver function tests (ALT, AST, alkaline phosphatase, GGT, bilirubin) are far superior for detecting and characterizing hepatic dysfunction 1

When LDH Has Clinical Utility in Hepatic Contexts

Differentiating Acute Liver Injury Patterns

  • The ALT/LD ratio can distinguish viral hepatitis from ischemic hepatitis or acetaminophen toxicity: 4
    • Viral hepatitis: ALT/LD ratio = 4.65 (LD relatively low)
    • Ischemic hepatitis: ALT/LD ratio = 0.87 (LD markedly elevated)
    • Acetaminophen injury: ALT/LD ratio = 1.46 (LD moderately elevated)
  • An ALT/LD ratio >1.5 differentiates viral hepatitis from ischemic/toxic injury with 94% sensitivity and 84% specificity 4

Specific Pregnancy-Related Liver Conditions

  • In HELLP syndrome (Hemolysis, Elevated Liver enzymes, Low Platelets), LDH elevation is part of the diagnostic criteria alongside hemolysis markers and thrombocytopenia 1
  • In acute fatty liver of pregnancy (AFLP), elevated LDH (>42 IU/L by Swansea criteria) supports diagnosis but is nonspecific 1

Peritoneal Fluid Analysis

  • In suspected secondary peritonitis from perforated viscus, ascitic LDH levels higher than serum LDH suggest this diagnosis 2

Proper Liver Function Assessment

Standard First-Line Tests 1

  • Aminotransferases (ALT, AST): Primary markers of hepatocellular injury
  • Alkaline phosphatase (ALP) and GGT: Markers of cholestasis
  • Bilirubin (total and direct): Measures hepatic excretory function
  • Albumin and INR: Assess synthetic liver function
  • Complete blood count and platelet count: Evaluate for complications

Risk Stratification in Specific Contexts

  • For NAFLD: Use FIB-4 or NAFLD Fibrosis Score, not LDH 1
  • For alcohol-related liver disease: Use Fibroscan/ARFI elastography for fibrosis assessment 1

Critical Pitfalls to Avoid

  • Do not order LDH as a routine liver function test—it adds no diagnostic value and may lead to unnecessary workup of nonspecific elevations 1, 2
  • Do not interpret isolated LDH elevation as indicating liver disease without considering the numerous other causes (hemolysis, malignancy, myocardial infarction, etc.) 2, 3
  • Hemolyzed blood samples falsely elevate LDH—always verify specimen quality before interpreting results 3
  • Very high isolated LDH (>800 IU/L) is more commonly associated with malignancy (27% of cases) or infection (57% of cases) than primary liver disease 5

When to Consider LDH in Hepatic Evaluation

  • Only when differentiating acute hepatocellular injury patterns (viral vs. ischemic vs. toxic) using the ALT/LD ratio 4
  • In pregnancy with suspected HELLP syndrome or AFLP, as part of comprehensive evaluation 1
  • When evaluating ascitic fluid in suspected peritonitis 2
  • Never as a standalone or primary liver function marker 1, 2

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Elevated Lactate Dehydrogenase (LDH) Causes and Interpretation

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Clinical Significance of Elevated Lactate Dehydrogenase Levels

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.